Stoke Therapeutics, Inc. (STOK): Auditor change
Severity scores the disclosed filing signal, not a judgment about the company or its securities.
What was disclosed
Stoke Therapeutics, Inc. disclosed a change of its independent registered public accounting firm (8-K Item 4.01).
Why it matters
A change of independent auditor, especially with disclosed disagreements, is an audit and governance signal.